Trexquant Investment LP - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2019$103,000
-89.4%
16,924
-89.9%
0.01%
-87.0%
Q1 2019$975,000
+235.1%
167,889
+1018.1%
0.07%
+213.6%
Q3 2018$291,000
-69.9%
15,015
-60.3%
0.02%
-67.2%
Q2 2018$966,000
+189.2%
37,794
+126.8%
0.07%
+81.1%
Q4 2017$334,000
+85.6%
16,661
+36.8%
0.04%
-24.5%
Q2 2017$180,000
-61.6%
12,177
-67.3%
0.05%
-33.8%
Q4 2016$469,000
+34.0%
37,238
+197.7%
0.07%
-5.1%
Q3 2016$350,000
-32.3%
12,509
-17.2%
0.08%
+69.6%
Q4 2015$517,000
+84.6%
15,109
+139.8%
0.05%
+48.4%
Q2 2015$280,0006,3000.03%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q1 2018
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 7,036,670$42,853,0001.54%
ARMISTICE CAPITAL, LLC 3,200,000$19,488,0001.23%
STEPHENS INC /AR/ 6,600,015$40,194,0000.91%
S&T BANK/PA 610,367$3,718,0000.82%
Rhenman & Partners Asset Management AB 1,203,405$7,329,0000.81%
Matarin Capital Management, LLC 701,445$4,272,0000.30%
Investors Research Corp 89,727$546,0000.28%
Advisory Services Network, LLC 598,802$3,647,0000.22%
FCG ADVISORS, LLC 34,000$207,0000.06%
EVERENCE CAPITAL MANAGEMENT INC 52,730$321,0000.05%
View complete list of DIPLOMAT PHARMACY INC shareholders